Dr. Rebecca Redman, MD
Claim this profileJames Graham Brown Cancer Center
Studies Squamous Cell Carcinoma
Studies Cancer
16 reported clinical trials
29 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage III
PD-L1 positive
2Cancer
Stage IV
Stage III
MSI-H positive
Affiliated Hospitals
Clinical Trials Rebecca Redman, MD is currently running
NDI-219216
for Cancer
The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main questions it aims to answer are: Is NDI-219216 safe and what kinds of side effects might it cause? What kind of effects does NDI-219216 have on the body? Does NDI-219216 have any impact on tumor size? Participants will: Take NDI-219216 every day by mouth. Visit the clinic 6 times during Cycle 1, 2 times during Cycle 2, once a month thereafter for checkups and tests while on the study, then one time for an end of treatment visit. After the End of Study, a follow up will occur but can be done on the phone. Keep a diary of their tablet consumption and symptoms experienced.
Recruiting1 award Phase 1 & 22 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
More about Rebecca Redman, MD
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Rebecca Redman, MD has experience with
- Pembrolizumab
- Nivolumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- PFK-158
- Stereotactic Body Radiation Therapy
Breakdown of trials Rebecca Redman, MD has run
Squamous Cell Carcinoma
Lung Cancer
Oropharyngeal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca Redman, MD specialize in?
Rebecca Redman, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Rebecca Redman, MD currently recruiting for clinical trials?
Yes, Rebecca Redman, MD is currently recruiting for 4 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Rebecca Redman, MD has studied deeply?
Yes, Rebecca Redman, MD has studied treatments such as Pembrolizumab, Nivolumab, Cisplatin.
What is the best way to schedule an appointment with Rebecca Redman, MD?
Apply for one of the trials that Rebecca Redman, MD is conducting.
What is the office address of Rebecca Redman, MD?
The office of Rebecca Redman, MD is located at: James Graham Brown Cancer Center, Louisville, Kentucky 40202 United States. This is the address for their practice at the James Graham Brown Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.